Recruitment

Recruitment Status
Completed
Estimated Enrollment
148

Inclusion Criterias

Patients with moderate or severe renal insufficiency
All patients give written informed consent
Patients with Type 2 Diabetes Mellitus
Patients with moderate or severe renal insufficiency
All patients give written informed consent
Patients with Type 2 Diabetes Mellitus

Exclusion Criterias

Has active liver disease
Has type 1 diabetes mellitus or a history of ketoacidosis
Is on dialysis or is likely to need dialysis during the study
Has active liver disease
Has type 1 diabetes mellitus or a history of ketoacidosis
Is on dialysis or is likely to need dialysis during the study

Summary

Conditions
Type 2 DM Patients With Moderate or Severe Renal Impairment
Type
Interventional
Phase
Phase 3
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Double (Participant, Investigator)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 19 years and 75 years
Gender
Both males and females

Inclusion Criterias

Patients with moderate or severe renal insufficiency
All patients give written informed consent
Patients with Type 2 Diabetes Mellitus
Patients with moderate or severe renal insufficiency
All patients give written informed consent
Patients with Type 2 Diabetes Mellitus

Exclusion Criterias

Has active liver disease
Has type 1 diabetes mellitus or a history of ketoacidosis
Is on dialysis or is likely to need dialysis during the study
Has active liver disease
Has type 1 diabetes mellitus or a history of ketoacidosis
Is on dialysis or is likely to need dialysis during the study

Locations

Seoul
Seoul

Tracking Information

NCT #
NCT01968044
Collaborators
Not Provided
Investigators
  • Principal Investigator: DR Cha, MD, Ph.D Korea University
  • DR Cha, MD, Ph.D Korea University